Ariosa, Illumina Spar Over Patent Timing In DNA Test Trial

Law360, San Francisco (January 9, 2018, 10:11 PM EST) -- An attorney for Ariosa pressed a former Illumina scientist on whether an article describing Ariosa's prenatal testing method predated his patent protecting similar technology, in a bid to knock out infringement claims during the first day of testimony Tuesday in a California federal jury trial.

Richard Rava, one of the founding scientists at Verinata Health Inc., which was later acquired by Illumina, said a paper on Ariosa's prenatal test tipped him off to its infringement. Rava said the technology described in the scientific article tracked closely with Verinata's U.S. Patent No. 8,318,430. The patent protects a method for isolating and testing...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!